Alvotech Files February 2024 6-K Report

Ticker: ALVOW · Form: 6-K · Filed: Mar 1, 2024 · CIK: 1898416

Alvotech 6-K Filing Summary
FieldDetail
CompanyAlvotech (ALVOW)
Form Type6-K
Filed DateMar 1, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

Alvotech filed its monthly 6-K, confirming it's a foreign private issuer reporting under Form 20-F.

AI Summary

Alvotech, a biopharmaceutical company, filed a Form 6-K on March 1, 2024, for the month of February 2024. The filing indicates that Alvotech is a foreign private issuer and will file annual reports under Form 20-F. The company's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.

Why It Matters

This filing provides routine updates for investors regarding Alvotech's status as a foreign private issuer and its reporting obligations.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain material new information that would typically impact risk.

Key Players & Entities

  • Alvotech (company) — Registrant
  • Form 6-K (document) — Filing type
  • Form 20-F (document) — Annual report form
  • Luxembourg (location) — Principal executive office location

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.

Which form does Alvotech use for its annual reports?

Alvotech indicates it files annual reports under cover of Form 20-F.

What is Alvotech's principal executive office address?

Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.

For which month is this Form 6-K report filed?

This Form 6-K report is filed for the month of February 2024.

Is Alvotech submitting this Form 6-K in paper format?

The filing does not indicate that Alvotech is submitting the Form 6-K in paper format as permitted by Regulation S-T Rule 101(b)(1).

Filing Stats: 325 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-03-01 12:16:27

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: February 29, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.